Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Erwan Muros-Le Rouzic"'
Autor:
Erwan Muros-Le Rouzic, Yanic Heer, Sean Yiu, Viola Tozzi, Stefan Braune, Philip van Hövell, Arnfin Bergmann, Corrado Bernasconi, Fabian Model, Licinio Craveiro
Publikováno v:
Journal of Central Nervous System Disease, Vol 16 (2024)
Background Clinical trials comparing the efficacy of ocrelizumab (OCR) with other disease-modifying therapies (DMTs) other than interferon (IFN) β-1a in relapsing multiple sclerosis (RMS) are lacking. Objectives To compare the treatment effect of OC
Externí odkaz:
https://doaj.org/article/2fb3be10dac24259ab01d29ffa45fae4
Autor:
Stefan Braune, Sandra Bluemich, Carola Bruns, Petra Dirks, Jeanette Hoffmann, Yanic Heer, Erwan Muros-Le Rouzic, Arnfin Bergmann, NTD Study Group
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Primary progressive multiple sclerosis (PPMS) is characterised by gradual worsening of disability from symptom onset. Knowledge about the natural course of PPMS remains limited. Methods PPMS patients from the German NeuroTransData
Externí odkaz:
https://doaj.org/article/780b688fc1104ba297286bb662c40564
Autor:
Erwan Muros-Le Rouzic, Marco Ghiani, Evi Zhuleku, Anja Dillenseger, Ulf Maywald, Thomas Wilke, Tjalf Ziemssen, Licinio Craveiro
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundThe Expanded Disability Status Scale (EDSS) quantifies disability and measures disease progression in multiple sclerosis (MS), however is not available in administrative claims databases.ObjectivesTo develop a claims-based algorithm for der
Externí odkaz:
https://doaj.org/article/e2ea7fd792b7415fae46848feddc77d2
Autor:
Martin S. Weber, Mathias Buttmann, Sven G. Meuth, Petra Dirks, Erwan Muros-Le Rouzic, Julius C. Eggebrecht, Stefanie Hieke-Schulz, Jost Leemhuis, Tjalf Ziemssen
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundReal-world relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS) populations may be more diverse than in clinical trials. Here, we present a first analysis of safety, adherence and persistence data from a real-world cohort of
Externí odkaz:
https://doaj.org/article/5c361ada58c94ccf8af5b50ba90fce7e
Autor:
Céline Faure, Alfred Hager, Yuli Y. Kim, Daniel W. Rosenberg, Paul Clift, Lars Søndergaard, Jamil Aboulhosn, Wayne J Franklin, Markus Schwerzmann, Erwan Muros-Le Rouzic, Yves d'Udekem
Publikováno v:
Søndergaard, L, Aboulhosn, J, D'Udekem, Y, Faure, C, Franklin, W J, Hager, A, Kim, Y Y, Muros-Le Rouzic, E, Rosenberg, D, Schwerzmann, M & Clift, P 2022, ' Adolescents and adults with Fontan circulation : insights from the PREpArE-Fontan registry ', Cardiology in the Young, vol. 32, no. 4, pp. 597-605 . https://doi.org/10.1017/S1047951121002791
Søndergaard, Lars; Aboulhosn, Jamil; d'Udekem, Yves; Faure, Céline; Franklin, Wayne J; Hager, Alfred; Kim, Yuli Y; Muros-Le Rouzic, Erwan; Rosenberg, Daniel; Schwerzmann, Markus; Clift, Paul (2022). Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry. Cardiology in the young, 32(4), pp. 597-605. Cambridge University Press 10.1017/S1047951121002791
Søndergaard, Lars; Aboulhosn, Jamil; d'Udekem, Yves; Faure, Céline; Franklin, Wayne J; Hager, Alfred; Kim, Yuli Y; Muros-Le Rouzic, Erwan; Rosenberg, Daniel; Schwerzmann, Markus; Clift, Paul (2022). Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry. Cardiology in the young, 32(4), pp. 597-605. Cambridge University Press 10.1017/S1047951121002791
The Patient Registry for Adolescents and Adults with Stable Fontan Circulation aims to describe a contemporary cohort of Fontan patients who could be eligible for a clinical trial investigating macitentan, an endothelin receptor antagonist. This inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4cf94f2fc9ab96a1b59317977ac9fb
https://doi.org/10.1017/s1047951121002791
https://doi.org/10.1017/s1047951121002791
Autor:
Janick Weberpals, Spyros Roumpanis, Yael Barer, Sharon Ehrlich, Nikki Jessop, Rosetta Pedotti, Adi Vaknin-Dembinsky, Livnat Brill, Gabriel Chodick, Erwan Muros-Le Rouzic
Publikováno v:
Multiple sclerosis and related disorders. 68
The coronavirus disease 2019 (COVID-19) pandemic caused challenges in the management of patients living with multiple sclerosis (PLwMS). We investigated the occurrence and severity of COVID-19 infection post-vaccination among PLwMS treated with ocrel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff51c4e66c4c441b6e59a4b7365822e3
https://pubmed.ncbi.nlm.nih.gov/36081277
https://pubmed.ncbi.nlm.nih.gov/36081277
Autor:
Rachel Knapp, Fränce Hardtstock, Julia Krieger, Thomas Wilke, Ulf Maywald, Cathy Chognot, Erwan Muros-Le Rouzic, Licinio Craveiro
Publikováno v:
Multiple sclerosis and related disorders. 68
People with multiple sclerosis (pwMS) have a higher risk of serious infection (i.e., infection-related hospitalizations) than people without MS. Few studies have explored the risk of serious infections by MS phenotype in a real-world setting. This re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a25846a56b24de9fdb232023ebf4aa7a
https://pubmed.ncbi.nlm.nih.gov/36306609
https://pubmed.ncbi.nlm.nih.gov/36306609
Autor:
Rachel Knapp, Fränce Hardtstock, Thomas Wilke, Ulf Maywald, Cathy Chognot, Licinio Craveiro, Erwan Muros-Le Rouzic
Publikováno v:
Multiple Sclerosis and Related Disorders. 72:104583
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2da804c4f166058a427e6d9cae39413d
https://doi.org/10.1016/j.msard.2023.104583
https://doi.org/10.1016/j.msard.2023.104583
Autor:
Paul Dillon, Athanasios Siadimas, Spyros Roumpanis, Otto Fajardo, Kocho Fitovski, Nikki Jessop, Louise Whitley, Erwan Muros-Le Rouzic
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104512
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1096a525ae0caae57586cac7f1812746
https://doi.org/10.1016/j.msard.2023.104512
https://doi.org/10.1016/j.msard.2023.104512
Autor:
Gisella Guerrera, Alessandra Mandelli, Annamaria Finardi, Mario Orrico, Silvia D’Orso, Mario Picozza, Maddalena Noviello, Valeria Beretta, Bruno Bonetti, Massimiliano Calabrese, Damiano Marastoni, Nicola De Rossi, Ruggero Capra, Marco Salvetti, Maria Chiara Buscarinu, Matilde Inglese, Antonio Uccelli, Lucia Moiola, Catarina Raposo, Erwan Muros-Le Rouzic, Rosetta Pedotti, Massimo Filippi, Chiara Bonini, Luca Battistini, Giovanna Borsellino, Roberto Furlan
Background: Development of long-lasting anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) T-cell responses in persons with multiple sclerosis (pwMS) treated with ocrelizumab is questioned. Objective: Investigate antiviral T-cell respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54222c76235dd579bf4fdc869e5ef5ed
http://hdl.handle.net/11562/1068947
http://hdl.handle.net/11562/1068947
